101661: Drug Abuse Treatment Evidence: Collection VII (NIDA Notes)

About the Course:

This course is based on three NIDA Notes articles. NIDA Notes is a large collection of brief, relevant articles focusing on current drug abuse treatment evidence.

Combination Treatment Extends Marijuana Abstinence
describes how vouchers provide a strong incentive for abstinence during treatment, and cognitive-behavioral therapy helps patients maintain abstinence after treatment ends.

Sertraline Does Not Help Methamphetamine Abusers Quit
describes how selective serotonin reuptake inhibitors do not relieve the depressive symptoms of methamphetamine withdrawal and may produce unpleasant side effects.

NIDA’s Newest Division Mines Clinical Applications From Basic Research
acknowledges how NIDA’s Division of Clinical Neuroscience and Behavioral Research (DCNBR) identifies, validates, and explores the clinical implications of basic science discoveries.

All three articles are contained in one PDF.

Journal/Publisher:

NIDA

Publication Date:

March 2008; and October 2007

Authors

Debra P. Davis; Elizabeth Ashton

About the Authors:

Debra P. Davis is the NIDA Notes senior editor.

Elizabeth Ashton is a NIDA Notes staff writer.

Recommended For:

This course is recommended for health care professionals, especially addiction counselors, psychologists, mental health counselors, social workers, and nurses who seek knowledge about how combination treatment extends marijuana abstinence; how sertraline does not help methamphetamine abusers quit; and how NIDA’s newest division mines clinical applications from basic research. It is appropriate for introductory to intermediate levels of participants’ knowledge.

Course Objectives:

1. Recognize how the combination treatment of vouchers and cognitive-behavioral therapy extends marijuana abstinence.

2. Explain how sertraline does not help methamphetamine abusers quit.

3. Describe how NIDA’s Division of Clinical Neuroscience and Behavioral Research (DCNBR) identifies, validates, and explores the clinical implications of basic science discoveries.